ACRE issues collaboration guidance

The Association of Clinical Researchers and Educators (ACRE) issued a code of conduct to guide doctors in what it considers major areas of interaction with health-related industries.

The aim is to help doctors decide whether, or how, to be involved in consulting, advising, CME, peer-to-peer speakers' programs, research or other industry collaborations, ACRE says.

They discourage ghostwriting, define what constitutes “fair value” for receiving compensation, and address such areas as formulary committees and institutional review boards.

ACRE also offers recommendations on how physicians should disclose working relationships and calls for a formal rejection of the terms “conflict of interest” and “competing interests.”

“These terms are largely pejorative,” the recommendations say, in that they infer that “the person making such a disclosure has accepted financial or other rewards in return for statements or advocacy that are not in the best interests of patient care or scientific integrity.”

Guidelines were co-authored by Michael Weber, MD, of SUNY Downstate College of Medicine, along with Harvard Medical School's Thomas Stossel, MD, and other ACRE members.

“These guidelines achieve a much more reasonable approach to managing relationships so that physicians can actively participate in innovation and discovery of new treatment,” said J. Michael Gonzalez-Campoy, MD, PhD, a co-author, in a statement.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.